Epista Life Science completed the acquisition of Genau & More.

Epista Life Science, a consultancy dedicated to continuously improving regulatory compliance, completed the acquisition of Genau & More, a company specializing in engineering and consulting services for the Life Science industry. Financial terms were not disclosed. “Genau & More is an incredibly good and respected name in the industry. They are widely recognized for their long-term approach to regulatory strategies, inspection readiness, training, and validation of e.g., equipment and IT. They keep their promises and invest heavily in their client relationships with the vision of making business and patient safety go hand-in-hand. The combination of deep professional consulting capabilities and technological competence at Epista Life Science and strategic quality and compliance advice at the highest level at Genau & More will create many new opportunities to reduce our clients' time-to-market and, at the same time, increase quality and predictability. We are on a joint mission to drive a positive impact on an industry critical to society - an industry that, in many ways, we in Denmark are helping to shape and influence in a positive direction,” Klavs Esbjerg, Epista CEO.